EXOZ
Healthcare BiotechnologyeXoZymes, Inc.
$5.52
-0.03 -0.58% today
Price History
Not enough data
Key Stats
Market Cap
51.36M
Avg Volume
6,952
EPS
-$1.19
52W High
$18.40
52W Low
$4.35
Div. Yield
0.0%
Valuation
P/B Ratio
14.01
EV/EBITDA
-4.55
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Equity
(187.2%)
Return on Assets
(74.7%)
Liquidity & Leverage
Current Ratio
3.81
Quick Ratio
3.63
Debt / Equity
0.30
Total Cash
5.65M
Total Debt
1.09M
About
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
www.exozymes.com